Virginia-Maryland College of Veterinary Medicine
Results for: Animal Cancer Care and Research Center
Animal Cancer Care and Research Center
-
Article ItemGolden retriever’s cancer treatment gives veterinary student perspective as pet owner , article
A dog owner, a veterinary clinic assistant and a veterinary college student might see advanced radiation treatment of a pet from somewhat different perspectives. But Taylor Layton sees it from all three at once.
-
Article ItemOncology internship at ACCRC helps guide journey from RVT to DVM for Maryland community college student , article
As I stepped through the double doors into the bright hallway, hearing cheerful morning greetings and seeing the wagging tail of an alert German shepherd, I knew I was about to open up a new world of opportunity in my journey to becoming a veterinarian.
-
Article ItemPet owners join forces with veterinary oncologists to unravel cancer mysteries through clinical trials , article
The Animal Cancer Care and Research Center(ACCRC) is increasing its clinical trials as it seeks to develop better treatments for several types of cancer. Clinical trials are essential for modern medicine, enabling research and development of new therapies, drugs, and techniques to fight diseases. But these advances can only happen with the support of pet owners and their participating pets.
-
Article ItemResearch program ‘exceeds expectations’ in first two years of Animal Cancer Care and Research Center at Roanoke , article
The Animal Cancer Care and Research Center (ACCRC) recently celebrated two years since its opening in Roanoke beside Virginia Tech’s Fralin Biomedical Research Institute (FBRI) in the Riverside Center for Research and Technology.
-
Article ItemNo bands, no confetti, but still grand for the region's pets , article
In September, the opening of the Animal Cancer Care and Research Center on the Virginia Tech Carilion Health Sciences Campus in Roanoke, Virginia, finalized the relocation of VA-MD Vet Med's oncology service from the Veterinary Teaching Hospital on the Blacksburg campus.
-
Article ItemTrained in human medicine, four times bereaved by cancer, MaLora Bush finds purpose in treating pets , article
For four close family members who died of cancer, for her three furry “babies” at home, MaLora Bush has found more than just a job she loves, but a life’s mission.
-
Article ItemFaculty Spotlight: Brittany Ciepluch , article
Brittany Ciepluch, DVM, MS, DACVS–Small Animal Clinical Assistant Professor, Surgical Oncology
-
Article ItemFocal Medical-Virginia Tech Press Release , article
Cary, NC and Roanoke, VA, May 04, 2023 — Focal Medical, Inc., a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform today announced the initiation of a research study in collaboration with Virginia Tech’s Animal Cancer Care and Research Center.
-
Article ItemTransdisciplinary collaborations essential to tackling cancer , article
A Virginia Tech research team led by veterinary oncologic surgeon Joanne Tuohy and biomedical engineer Eli Vlaisavljevich is working to refine a unique approach to treating canine osteosarcoma.
-
Article ItemCancer treatment and Petco Love funds change elderly dog’s life , article
Petco Love’s support of the Virginia Tech Animal Cancer Care and Research Center (ACCRC) in Roanoke has allowed patients to access cancer therapies and treatments, resulting in enhanced lives and more treatment options.
-
Article ItemMona Lisa keeps making smiles thanks to cancer treatment, Petco Love funds , article
When adopting a cat, some people pick out their new feline friend from pictures online. For Gary and Rebecca Davis, Mona Lisa—Mony for short—was different.
-
Article ItemInterdisciplinary team wins grant to develop drug for brain cancer , article
The National Institutes of Health is awarding a $3.8 million grant to John Rossmeisl, the Dr. and Mrs. Dorsey Taylor Mahin Professor of Neurology and Neurosurgery at the Virginia-Maryland College of Veterinary Medicine, and Waldemar Debinski, cancer biology professor at Wake Forest School of Medicine. The team will treat human brain cancer with a drug they have previously used to treat canines.